Endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: The first intervention group: Patients in this group were treated with dienogest at the rate of 2 mg/kg for 3 months, and then IVF was immediately performed on them. Intervention 2: Th
So that they receive a dose of medicine every 28 days. Then 15 days after the last dose, IVF is performed on them. Intervention 4: Fourth intervention group: For patients in this group, without receiv
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 45 Years
Inclusion criteria
Inclusion criteria: Infertile women Reproductive age 30-45 years Suffering from any of the stages 3 or 4 of endometriosis IVF candidate Consent to participate in the study
Exclusion criteria
Exclusion criteria: Any drug sensitivity History of thromboembolic diseases, malignancy Positive family history for thrombophilia Contraindication of contraceptive use, GnRH agonist Prohibition of pregnancy Having infectious diseases such as hepatitis B, C or HIV
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of human chorionic gonadotropin (B-HCG). Timepoint: After the intervention. Method of measurement: Urinalysis.;Endometrial thickness. Timepoint: Before and after the intervention. Method of measurement: Sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHatav Ghasemi Tehrani
Esfahan University of Medical Sciences
Outcome results
None listed